Author details

Full Name

Myriem Boufraqech

Affiliation

The University of Texas at Austin

ORCID

Career Start Year

2010

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36724254	CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors.	Proc Natl Acad Sci U S A	2023
36724254	CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors.	Proc Natl Acad Sci U S A	2023
35260660	Histone H2AX promotes metastatic progression by preserving glycolysis via hexokinase-2.	Sci Rep	2022
36151566	Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.	J Exp Clin Cancer Res	2022
35260660	Histone H2AX promotes metastatic progression by preserving glycolysis via hexokinase-2.	Sci Rep	2022
36151566	Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.	J Exp Clin Cancer Res	2022
32528402	New Therapies for Advanced Thyroid Cancer.	Front Endocrinol (Lausanne)	2020
31937621	A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).	Clin Cancer Res	2020
32528402	New Therapies for Advanced Thyroid Cancer.	Front Endocrinol (Lausanne)	2020
31937621	A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).	Clin Cancer Res	2020
30398411	Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.	Thyroid	2019
31835496	Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.	Cancers (Basel)	2019
30398411	Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.	Thyroid	2019
30910969	Histone H2AX promotes neuronal health by controlling mitochondrial homeostasis.	Proc Natl Acad Sci U S A	2019
31835496	Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.	Cancers (Basel)	2019
30910969	Histone H2AX promotes neuronal health by controlling mitochondrial homeostasis.	Proc Natl Acad Sci U S A	2019
29149451	Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.	Cancer	2018
30112163	68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor.	Int J Endocr Oncol	2018
30250647	Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.	Oncotarget	2018
29691295	Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>.	Clin Cancer Res	2018
29149451	Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.	Cancer	2018
30250647	Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.	Oncotarget	2018
30112163	68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor.	Int J Endocr Oncol	2018
29691295	Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>.	Clin Cancer Res	2018
28600475	Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.	Clin Cancer Res	2017
28600475	Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.	Clin Cancer Res	2017
27029493	Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.	Clin Cancer Res	2016
26934320	Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.	Oncotarget	2016
27296552	LOX is a novel mitotic spindle-associated protein essential for mitosis.	Oncotarget	2016
26876487	The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition.	Nat Commun	2016
26873959	Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.	Clin Cancer Res	2016
27029493	Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.	Clin Cancer Res	2016
26324161	FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization.	World J Surg	2016
27923454	MicroRNAs in the thyroid.	Best Pract Res Clin Endocrinol Metab	2016
26324161	FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization.	World J Surg	2016
27923454	MicroRNAs in the thyroid.	Best Pract Res Clin Endocrinol Metab	2016
27296552	LOX is a novel mitotic spindle-associated protein essential for mitosis.	Oncotarget	2016
26934320	Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.	Oncotarget	2016
26876487	The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition.	Nat Commun	2016
26873959	Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.	Clin Cancer Res	2016
25488748	miR30a inhibits LOX expression and anaplastic thyroid cancer progression.	Cancer Res	2015
25488748	miR30a inhibits LOX expression and anaplastic thyroid cancer progression.	Cancer Res	2015
25945839	Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.	Oncotarget	2015
25944801	Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer.	Clin Cancer Res	2015
25940539	Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.	Oncotarget	2015
25972243	Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.	Endocr Relat Cancer	2015
26224588	New genomic somatic amplifications and deletions in papillary thyroid cancer.	Endocrine	2015
26446994	Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.	Nucleic Acids Res	2015
26446994	Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.	Nucleic Acids Res	2015
26224588	New genomic somatic amplifications and deletions in papillary thyroid cancer.	Endocrine	2015

1 - 50 of 78

Yunyun Zhou

Children's Hospital of Philadelphia

Career Start Year 2015

Number of shared co-authors 0

Maxime Tarabichi

ULB-Cancer Research Center (U-CRC), Universite Libre de Bruxelles

Career Start Year 2012

Number of shared co-authors 1

Jack Zhu

Center for Cancer Research, National Cancer Institute Bethesda

Career Start Year 2010

Number of shared co-authors 8

Larissa A Pikor

Ottawa Hospital Research Institute

Career Start Year 2010

Number of shared co-authors 0

Cristina Ivan

The University of Texas MD Anderson Cancer Center

Career Start Year 2010

Number of shared co-authors 1

Alan L Ho

Memorial Sloan Kettering Cancer Center

Career Start Year 2009

Number of shared co-authors 0

Jennifer R Wang

The University of Texas MD Anderson Cancer Center

Career Start Year 2008

Number of shared co-authors 0

Katayoon Kasaian

Ontario Institute for Cancer Research

Career Start Year 2008

Number of shared co-authors 3

Salvatore Piscuoglio

University of Basel

Career Start Year 2008

Number of shared co-authors 0

Tuan Zea Tan

Cancer Science Institute of Singapore, National University of Singapore

Career Start Year 2005

Number of shared co-authors 0

Wei Li

The Ohio State University

Career Start Year 2005

Number of shared co-authors 1

Rebecca Nagy

Guardant Health Inc.

Career Start Year 2004

Number of shared co-authors 0

Lixia Diao

The University of Texas MD Anderson Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Sandya Liyanarachchi

The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center

Career Start Year 2002

Number of shared co-authors 2

Yuelin J Zhu

National Cancer Institute, National Institutes of Health

Career Start Year 2002

Number of shared co-authors 18

Sooryanarayana Varambally

University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center

Career Start Year 2001

Number of shared co-authors 0

Wei Zhang

Children's Hospital, Zhejiang University School of Medicine

Career Start Year 2001

Number of shared co-authors 0

Michelle D Williams

The University of Texas M. D. Anderson Cancer Center

Career Start Year 2001

Number of shared co-authors 1

Xuhong Cao

Michigan Center for Translational Pathology.

Career Start Year 1999

Number of shared co-authors 0

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 14

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 0

Huiling He

The Ohio State University Comprehensive Cancer Center

Career Start Year 1995

Number of shared co-authors 1

Richard T Kloos

Veracyte Inc.

Career Start Year 1995

Number of shared co-authors 0

Woong-Yang Park

Samsung Genome Institute, Samsung Medical Center

Career Start Year 1995

Number of shared co-authors 0

Tatsuhiro Shibata

Kurume University School of Medicine

Career Start Year 1993

Number of shared co-authors 6

Matthew D Ringel

The Ohio State University College of Medicine and Comprehensive Cancer Center

Career Start Year 1991

Number of shared co-authors 2

Thomas J Giordano

University of Michigan ann arbor

Career Start Year 1989

Number of shared co-authors 7

Patrick Kwok-Shing Ng

The University of Texas MD Anderson Cancer Center

Career Start Year 1987

Number of shared co-authors 0

Cuong Hoang-Vu

Center for Cancer Research, National Cancer Institute

Career Start Year 1985

Number of shared co-authors 5

Matthew Meyerson

Broad Institute

Career Start Year 1983

Number of shared co-authors 2

row(s) 1 - 30 of 30

Electron Kebebew

Stanford University School of Medicine

Co-authored papers 29

Lisa Zhang

National Institute of Child Health and Development

Co-authored papers 20

Naris Nilubol

Center for Cancer Research

Co-authored papers 18

Dhaval Patel

National Cancer Institute, National Institutes of Health

Co-authored papers 14

Sudheer Kumar Gara

National Cancer Institute, National Institutes of Health

Co-authored papers 9

Martha Quezado

National Cancer Institute (NCI), National Institutes of Health (NIH)

Co-authored papers 9

Min Shen

National Center for Advancing Translational Sciences, National Institutes of Health

Co-authored papers 8

Amit Mehta

Center for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth

Co-authored papers 6

Yaqin Zhang

Jiangsu University Zhenjiang 212013

Co-authored papers 5

Ryan J Ellis

Memorial Sloan Kettering Cancer Center

Co-authored papers 5

Mei He

Sichuan University

Co-authored papers 4

Meenu Jain

Georgia Cancer Center, Augusta University

Co-authored papers 4

Samira M Sadowski

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 4

Kelli Gaskins

Frederick National Laboratory for Cancer Research, National Institutes of Health

Co-authored papers 4

Susan R Davis

Co-authored papers 4

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 4

Yi Liu-Chittenden

Department of Biochemistry and Howard Hughes Medical Institute, Stanford University

Co-authored papers 3

Zhuyin Li

National Center for Advancing Translational Sciences, National Institutes of Health

Co-authored papers 3

Yonghong Wang

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 2

Sunita K Agarwal

National Institute of Diabetes and Digestive and Kidney Diseases